WO2008069919A3 - Methods & compositions for treating tissue using silk proteins - Google Patents

Methods & compositions for treating tissue using silk proteins Download PDF

Info

Publication number
WO2008069919A3
WO2008069919A3 PCT/US2007/024158 US2007024158W WO2008069919A3 WO 2008069919 A3 WO2008069919 A3 WO 2008069919A3 US 2007024158 W US2007024158 W US 2007024158W WO 2008069919 A3 WO2008069919 A3 WO 2008069919A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
component
peg
methods
treating tissue
Prior art date
Application number
PCT/US2007/024158
Other languages
French (fr)
Other versions
WO2008069919A2 (en
Inventor
Syed Hossainy
Michael Ngo
Mikael Trollsas
John Stankus
Gene Michal
Original Assignee
Abbott Cardiovascular Systems
Syed Hossainy
Michael Ngo
Mikael Trollsas
John Stankus
Gene Michal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Cardiovascular Systems, Syed Hossainy, Michael Ngo, Mikael Trollsas, John Stankus, Gene Michal filed Critical Abbott Cardiovascular Systems
Priority to EP07870900.3A priority Critical patent/EP2099509B1/en
Priority to JP2009539265A priority patent/JP5823094B2/en
Publication of WO2008069919A2 publication Critical patent/WO2008069919A2/en
Publication of WO2008069919A3 publication Critical patent/WO2008069919A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer

Abstract

Compositions for forming a self-reinforcing composite biomatrix, methods of manufacture and use therefore are herein disclosed. The compositions comprise a first component and a second component of a two-component gelation system and a silk protein or a block copolymer thereof. Said two- component gel system can be made of synthetic polymers (such as a combination of PEG thiol, PEG NHS, PEG amine or PEG diacrylate) or of fibrin glue. The' compositions may further comprise cells and/or growth factors.
PCT/US2007/024158 2006-12-04 2007-11-16 Methods & compositions for treating tissue using silk proteins WO2008069919A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07870900.3A EP2099509B1 (en) 2006-12-04 2007-11-16 Methods and compositions for treating tissue using silk proteins
JP2009539265A JP5823094B2 (en) 2006-12-04 2007-11-16 Tissue treatment method and composition using silk protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/566,643 2006-12-04
US11/566,643 US8192760B2 (en) 2006-12-04 2006-12-04 Methods and compositions for treating tissue using silk proteins

Publications (2)

Publication Number Publication Date
WO2008069919A2 WO2008069919A2 (en) 2008-06-12
WO2008069919A3 true WO2008069919A3 (en) 2008-10-09

Family

ID=39476093

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/024158 WO2008069919A2 (en) 2006-12-04 2007-11-16 Methods & compositions for treating tissue using silk proteins

Country Status (4)

Country Link
US (4) US8192760B2 (en)
EP (1) EP2099509B1 (en)
JP (2) JP5823094B2 (en)
WO (1) WO2008069919A2 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US6902932B2 (en) * 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
US20110009960A1 (en) * 2001-11-16 2011-01-13 Allergan, Inc. Prosthetic fabric structure
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US8821473B2 (en) 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8383158B2 (en) * 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
JP2009532490A (en) 2006-04-06 2009-09-10 ヌパス インコーポレイテッド Implants for the treatment of dopamine-related conditions
US7732190B2 (en) 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US8741326B2 (en) 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
US9833240B2 (en) 2008-02-18 2017-12-05 Covidien Lp Lock bar spring and clip for implant deployment device
US8808314B2 (en) 2008-02-18 2014-08-19 Covidien Lp Device and method for deploying and attaching an implant to a biological tissue
US8317808B2 (en) 2008-02-18 2012-11-27 Covidien Lp Device and method for rolling and inserting a prosthetic patch into a body cavity
US9044235B2 (en) 2008-02-18 2015-06-02 Covidien Lp Magnetic clip for implant deployment device
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device
US9398944B2 (en) 2008-02-18 2016-07-26 Covidien Lp Lock bar spring and clip for implant deployment device
US8758373B2 (en) 2008-02-18 2014-06-24 Covidien Lp Means and method for reversibly connecting a patch to a patch deployment device
US9393002B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device
US9034002B2 (en) 2008-02-18 2015-05-19 Covidien Lp Lock bar spring and clip for implant deployment device
EP2247245B1 (en) 2008-02-18 2017-06-28 Covidien LP A device for deploying and attaching a patch to a biological tissue
US9301826B2 (en) 2008-02-18 2016-04-05 Covidien Lp Lock bar spring and clip for implant deployment device
US9089700B2 (en) * 2008-08-11 2015-07-28 Cibiem, Inc. Systems and methods for treating dyspnea, including via electrical afferent signal blocking
WO2010025176A2 (en) * 2008-08-28 2010-03-04 Organogenesis, Inc. Mcp-1 delivery system
EP2792307B1 (en) 2008-10-20 2017-10-04 Covidien LP A device for attaching a patch to a biological tissue
FR2937974B1 (en) * 2008-10-30 2013-01-11 Univ Bordeaux 1 BLOCK COPOLYMERS BASED ON POLYSACCHARIDE AND POLYPEPTIDE, VESICLES COMPRISING THESE COPOLYMERS AND THEIR USE
AU2009316594B2 (en) * 2008-11-20 2014-05-01 Lifecell Corporation Method for treatment and prevention of parastomal hernias
US9308070B2 (en) * 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
JP5653931B2 (en) 2008-12-15 2015-01-14 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ Prosthetic device and manufacturing method thereof
US9204954B2 (en) * 2008-12-15 2015-12-08 Allergan, Inc. Knitted scaffold with diagonal yarn
US9326840B2 (en) 2008-12-15 2016-05-03 Allergan, Inc. Prosthetic device and method of manufacturing the same
US9204953B2 (en) 2008-12-15 2015-12-08 Allergan, Inc. Biocompatible surgical scaffold with varying stretch
US20110111031A1 (en) * 2009-04-20 2011-05-12 Guang-Liang Jiang Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof
US20110052695A1 (en) * 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
EP2421551B2 (en) * 2009-04-20 2020-07-15 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US20110189292A1 (en) * 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
WO2011021083A1 (en) 2009-08-17 2011-02-24 PolyTouch Medical, Inc. Articulating patch deployment device and method of use
EP2467066B1 (en) 2009-08-17 2019-03-27 Covidien LP Means for reversibly connecting an implant to a deployment device
NZ598691A (en) * 2009-09-11 2014-05-30 Allergan Inc Prosthetic device and method of manufacturing the same
US8968785B2 (en) * 2009-10-02 2015-03-03 Covidien Lp Surgical compositions
JP2013509448A (en) * 2009-11-02 2013-03-14 ニューパス インコーポレーテッド How to treat Parkinson's disease
ES2811027T3 (en) * 2010-02-19 2021-03-10 Lifecell Corp Devices for the treatment of the abdominal wall
US9758558B2 (en) 2010-04-01 2017-09-12 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Whey protein isolate hydrogels and their uses
WO2012009682A2 (en) * 2010-07-15 2012-01-19 The Board Of Trustees Of The Leland Stanford Junior University Elastic substrates and methods of use in cell manipulation and culture
US8524215B2 (en) 2010-08-02 2013-09-03 Janssen Biotech, Inc. Absorbable PEG-based hydrogels
US9566365B2 (en) 2010-09-01 2017-02-14 Trustees Of Tufts College Silk fibroin and polyethylene glycol-based biomaterials
WO2012040310A2 (en) * 2010-09-22 2012-03-29 Virginia Commonwealth University Preparation rich in growth factor-based fibrous matrices for tissue engineering, growth factor delivery, and wound healing
CN102174203B (en) * 2011-03-29 2012-12-26 苏州大学 Method for preparing silk fibroin/copolymer hydrogel
CA2829804A1 (en) * 2011-03-29 2012-10-04 Geron Corporation Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells
WO2013096249A1 (en) 2011-12-20 2013-06-27 Lifecell Corporation Sheet tissue products
ES2726105T3 (en) 2011-12-20 2019-10-01 Lifecell Corp Fluidizable fabric products
US9271821B2 (en) 2012-01-24 2016-03-01 Lifecell Corporation Elongated tissue matrices
EP2841115B1 (en) 2012-04-24 2019-07-10 LifeCell Corporation Functionalized tissue matrices
DE112013002175T5 (en) 2012-04-24 2015-01-22 Cibiem, Inc. Endovascular catheters and procedures for ablation of the carotid body
EP2842574B1 (en) * 2012-04-25 2018-12-19 Hitachi Chemical Co., Ltd. Sustained release carrier for drugs
WO2013181660A1 (en) 2012-06-01 2013-12-05 Cibiem, Inc. Methods and devices for cryogenic carotid body ablation
US9398930B2 (en) 2012-06-01 2016-07-26 Cibiem, Inc. Percutaneous methods and devices for carotid body ablation
EP2866669A4 (en) 2012-06-30 2016-04-20 Cibiem Inc Carotid body ablation via directed energy
WO2014039995A1 (en) 2012-09-07 2014-03-13 Fibrocell Technologies, Inc. Fibroblast compositions for treating cardial damage after an infarct
EP2961433A4 (en) * 2013-02-28 2016-11-30 Univ Ramot Peptide-based hydrogel particles and uses thereof
US20160022872A1 (en) * 2013-03-06 2016-01-28 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cell-based compositions, cell-based bandage devices and systems and methods of treatment therewith
US20160193106A1 (en) * 2013-08-20 2016-07-07 Wake Forest University Health Sciences Tissue repair devices utilizing self-assembled materials
US9512279B2 (en) * 2013-12-18 2016-12-06 Universite Cegy-Pontoise Interpenetrating polymer network
WO2015138795A1 (en) 2014-03-12 2015-09-17 Cibiem, Inc. Carotid body ablation with a transvenous ultrasound imaging and ablation catheter
WO2015157681A1 (en) * 2014-04-11 2015-10-15 Vitruvian Medical Devices, Inc. Microparticles for wound treatment
CN107405277B (en) 2014-12-02 2021-08-10 丝绸医疗公司 Silk performance garments and products and methods of making same
US11512425B2 (en) 2015-07-14 2022-11-29 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same
KR101637883B1 (en) * 2015-09-30 2016-07-21 선바이오(주) Polyethylene glycol hydrogel injection
CA3004745A1 (en) 2015-11-12 2017-05-18 University Of Virginia Patent Foundation Compositions and methods for vas-occlusive contraception and reversal thereof
CN106075575A (en) * 2016-06-28 2016-11-09 福州大学 A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof
IT201700036930A1 (en) * 2017-04-04 2018-10-04 Silk Biomaterials S R L System that includes hydrogels and nanofibres
AU2018280236A1 (en) 2017-06-07 2020-01-16 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US11390988B2 (en) 2017-09-27 2022-07-19 Evolved By Nature, Inc. Silk coated fabrics and products and methods of preparing the same
JP7319266B2 (en) 2017-11-13 2023-08-01 シファメド・ホールディングス・エルエルシー Intravascular fluid transfer devices, systems and methods of use
CN112004563A (en) 2018-02-01 2020-11-27 施菲姆德控股有限责任公司 Intravascular blood pump and methods of use and manufacture
WO2020084558A1 (en) * 2018-10-26 2020-04-30 Istituto Oncologico Veneto Iov-Irccs Hyaluronic acid as a natural adjuvant for protein and peptide-based vaccines
EP3996797A4 (en) 2019-07-12 2023-08-02 Shifamed Holdings, LLC Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
CA3217013A1 (en) * 2021-04-21 2022-10-27 Ohio State Innovation Foundation Nanofiber- and nanowhisker-based transfection platforms for bulk electroporation
WO2023118388A1 (en) * 2021-12-23 2023-06-29 Dsm Ip Assets B.V. Synthetic biopolymers and their use in compositions for tissue repair

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818291A (en) * 1986-12-10 1989-04-04 Ajinomoto Co., Inc. Silk-fibroin and human-fibrinogen adhesive composition
WO2003022909A1 (en) * 2001-09-11 2003-03-20 Consorzio Per Gli Studi Universitari Method for the preparation of silk fibroin hydrogels
WO2004000915A2 (en) * 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof

Family Cites Families (280)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2194144B (en) 1986-08-22 1990-04-25 American Cyanamid Co Stable pharmaceutical gel preparation
US2512569A (en) 1947-09-26 1950-06-20 Jacob A Saffir Hypodermic needle
US3144868A (en) 1960-10-21 1964-08-18 Mario E Jascalevich Drainage and feeding cannulae
US3584624A (en) 1969-02-24 1971-06-15 Vincent L De Ciutiis Flexible intravenous catheter provided with cutting tip means
US3780733A (en) 1972-07-24 1973-12-25 Manzor M Martinez Catheter
US3890976A (en) 1972-10-26 1975-06-24 Medical Products Corp Catheter tip assembly
US3804097A (en) 1972-12-14 1974-04-16 P Rudie Method of irrigating and treating an abcess
US6436135B1 (en) 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
JPS60126170A (en) 1983-12-14 1985-07-05 テルモ株式会社 Catheter and its production
US5128326A (en) 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4617186A (en) 1984-12-28 1986-10-14 Alcon Laboratories, Inc. Sustained release drug delivery system utilizing bioadhesive polymers
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US4794931A (en) 1986-02-28 1989-01-03 Cardiovascular Imaging Systems, Inc. Catheter apparatus, system and method for intravascular two-dimensional ultrasonography
US5026350A (en) 1986-10-09 1991-06-25 Hakko Electric Machine Works Co., Ltd. Set of double needles for injecting liquid medicine
JPS6485272A (en) * 1986-12-10 1989-03-30 Ajinomoto Kk Adhesive
US5606019A (en) * 1987-10-29 1997-02-25 Protien Polymer Technologies, Inc. Synthetic protein as implantables
FR2627984B1 (en) 1988-03-03 1990-08-17 Sanofi Sa PULVERULENT COMPOSITION BASED ON ALGINATE FOR DENTAL IMPRESSIONS
US5372138A (en) 1988-03-21 1994-12-13 Boston Scientific Corporation Acousting imaging catheters and the like
US5588432A (en) 1988-03-21 1996-12-31 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US5116317A (en) 1988-06-16 1992-05-26 Optimed Technologies, Inc. Angioplasty catheter with integral fiber optic assembly
JP2836878B2 (en) 1988-08-24 1998-12-14 スリピアン，マービン，ジェイ Intraluminal sealing with biodegradable polymer material
US5749915A (en) 1988-08-24 1998-05-12 Focal, Inc. Polymeric endoluminal paving process
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5092848A (en) 1988-10-13 1992-03-03 Deciutiis Vincent L Intravenous catheter with built-in cutting tip and method for making the same
DE68928532T2 (en) * 1988-11-09 1998-05-28 Protein Polymer Tech Inc FUNCTIONAL SYNTHETIC PROTEIN POLYMER PRODUCED BY A RECOMBINANT METHOD
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
JPH0662678B2 (en) * 1988-11-28 1994-08-17 電気化学工業株式会社 Hyaluronic acid-immobilized protein and method for producing the same
US5049130A (en) 1988-12-23 1991-09-17 Cardiovascular Imaging Systems, Inc. System and method for pressure filling of catheters
DE3908183C5 (en) 1989-03-14 2005-01-05 Kiekert Ag Motor vehicle door lock
JPH02145600U (en) 1989-05-15 1990-12-11
US5109859A (en) 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
US5024234A (en) 1989-10-17 1991-06-18 Cardiovascular Imaging Systems, Inc. Ultrasonic imaging catheter with guidewire channel
US5485486A (en) 1989-11-07 1996-01-16 Qualcomm Incorporated Method and apparatus for controlling transmission power in a CDMA cellular mobile telephone system
WO1991007154A1 (en) 1989-11-13 1991-05-30 President And Fellows Of Harvard College EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO
US5674192A (en) 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5811533A (en) 1990-06-11 1998-09-22 Nexstar Pharmaceuticals, Inc. High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
FR2668698B1 (en) 1990-11-06 1997-06-06 Ethnor SURGICAL INSTRUMENT FORMING TROCART.
US5202745A (en) 1990-11-07 1993-04-13 Hewlett-Packard Company Polarization independent optical coherence-domain reflectometry
WO1992011055A1 (en) 1990-12-17 1992-07-09 Cardiovascular Imaging Systems, Inc. Vascular catheter having low-profile distal end
US5171217A (en) 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US5465147A (en) 1991-04-29 1995-11-07 Massachusetts Institute Of Technology Method and apparatus for acquiring images using a ccd detector array and no transverse scanner
US6134003A (en) 1991-04-29 2000-10-17 Massachusetts Institute Of Technology Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope
DE69227902T3 (en) 1991-04-29 2010-04-22 Massachusetts Institute Of Technology, Cambridge DEVICE FOR OPTICAL IMAGING AND MEASUREMENT
SE9101853D0 (en) * 1991-06-17 1991-06-17 Jonas Wadstroem IMPROVED TISSUE ASHESIVE
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5291267A (en) 1992-01-22 1994-03-01 Hewlett-Packard Company Optical low-coherence reflectometry using optical amplification
DK0940123T3 (en) 1992-02-21 2004-05-17 Boston Scient Ltd Guide to ultrasound imaging
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
AU3941493A (en) 1992-03-30 1993-11-08 Alza Corporation Viscous suspensions of controlled-release drug particles
US5306250A (en) 1992-04-02 1994-04-26 Indiana University Foundation Method and apparatus for intravascular drug delivery
US5336252A (en) 1992-06-22 1994-08-09 Cohen Donald M System and method for implanting cardiac electrical leads
US5365325A (en) 1992-08-10 1994-11-15 Hitachi, Ltd. Method of multi-color recording using electro-photography process and apparatus therefor wherein mixed colors generation is prevented
US5672153A (en) 1992-08-12 1997-09-30 Vidamed, Inc. Medical probe device and method
DE4235506A1 (en) 1992-10-21 1994-04-28 Bavaria Med Tech Drug injection catheter
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6689608B1 (en) 1993-02-01 2004-02-10 Massachusetts Institute Of Technology Porous biodegradable polymeric materials for cell transplantation
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
EP2025353A2 (en) 1993-04-30 2009-02-18 Massachusetts Institute of Technology Injectable polysaccharide-cell compositions
US5437632A (en) 1993-06-02 1995-08-01 Target Therapeutics, Inc. Variable stiffness balloon catheter
US5725551A (en) 1993-07-26 1998-03-10 Myers; Gene Method and apparatus for arteriotomy closure
US5527322A (en) 1993-11-08 1996-06-18 Perclose, Inc. Device and method for suturing of internal puncture sites
JP2833456B2 (en) 1993-11-22 1998-12-09 株式会社東芝 Insertable ultrasound system
US5380292A (en) 1993-12-22 1995-01-10 Wilson-Cook Medical, Inc. Gastrointestinal needle mechanism
US5795331A (en) 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
FR2715855A1 (en) 1994-02-10 1995-08-11 Floch Serge Protector for syringe used with beta-radiation emitter
JP3591837B2 (en) 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド Biological bioadhesive composition containing fibrin glue and liposomes, method of manufacture and use thereof
US6334872B1 (en) 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
DE4408108A1 (en) 1994-03-10 1995-09-14 Bavaria Med Tech Catheter for injecting a fluid or a drug
US5464395A (en) 1994-04-05 1995-11-07 Faxon; David P. Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway
DE69535752D1 (en) 1994-04-13 2008-06-26 Biotransplant Inc ALPHA (1,3) GALACTOSYL TRANSFERASE NEGATIVE PIG
US5693085A (en) 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US6056744A (en) 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
US5621610A (en) 1994-06-30 1997-04-15 Compaq Computer Corporation Collapsible computer keyboard structure with associated collapsible pointing stick
US5580856A (en) 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
IL110367A (en) 1994-07-19 2007-05-15 Colbar Lifescience Ltd Collagen-based matrix
US6152141A (en) 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
US5516532A (en) 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5740808A (en) 1996-10-28 1998-04-21 Ep Technologies, Inc Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions
CA2202511A1 (en) 1994-10-12 1996-04-25 Laurence A. Roth Targeted delivery via biodegradable polymers
US6099864A (en) 1994-12-02 2000-08-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration In situ activation of microcapsules
FR2727692A1 (en) 1994-12-05 1996-06-07 Europ Propulsion GAS EXTRACTION DEVICE FOR A CHEMICAL STEAM INFILTRATION OVEN OR VAPOR DEPOSIT IN A PLANT FOR MANUFACTURING PARTS OF COMPOSITE MATERIAL
US5810885A (en) 1994-12-28 1998-09-22 Omrix Biopharm Sa Device for applying one or several fluids
US5919570A (en) 1995-02-01 1999-07-06 Schneider Inc. Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices
US5551427A (en) 1995-02-13 1996-09-03 Altman; Peter A. Implantable device for the effective elimination of cardiac arrhythmogenic sites
US5869127A (en) 1995-02-22 1999-02-09 Boston Scientific Corporation Method of providing a substrate with a bio-active/biocompatible coating
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US5669883A (en) 1995-04-12 1997-09-23 Symbiosis Corporation Veress needle and cannula assembly
US6251104B1 (en) 1995-05-10 2001-06-26 Eclipse Surgical Technologies, Inc. Guiding catheter system for ablating heart tissue
US5919449A (en) 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US5900433A (en) 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
US5693029A (en) 1995-07-10 1997-12-02 World Medical Manufacturing Corporation Pro-cell intra-cavity therapeutic agent delivery device
US6102904A (en) 1995-07-10 2000-08-15 Interventional Technologies, Inc. Device for injecting fluid into a wall of a blood vessel
US6143211A (en) 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
AU7254896A (en) 1995-10-05 1997-04-28 Genentech Inc. Improved angiogenesis using hepatocyte growth factor
ATE275880T1 (en) 1995-10-13 2004-10-15 Transvascular Inc DEVICE FOR BYPASSING ARTERIAL Narrowings AND/OR FOR PERFORMING OTHER TRANSVASCULAR PROCEDURES
US6726677B1 (en) 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US5642234A (en) 1995-10-30 1997-06-24 Lumatec Industries, Inc. Illuminated magnifying lens assembly
US6482231B1 (en) 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
EP0876165B1 (en) 1995-12-18 2006-06-21 Angiotech BioMaterials Corp. Crosslinked polymer compositions and methods for their use
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
JP2000502682A (en) 1995-12-22 2000-03-07 ローカルメッド インコーポレイテッド Local intravascular delivery of growth factors that promote angiogenesis
US6632436B2 (en) 1996-01-25 2003-10-14 Genitrix Llc Vaccine compositions and method of modulating immune responses
US5980866A (en) 1996-03-15 1999-11-09 Juridical Foundation The Chemosero-Therapeutic Research Institute Tissue adhesive suitable for spray application
DE69734060T2 (en) 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver PREPARATIONS AND METHODS FOR TREATING OR PREVENTING DISEASES OF THE BODY PASSAGE PATHS
US5939323A (en) 1996-05-28 1999-08-17 Brown University Hyaluronan based biodegradable scaffolds for tissue repair
US5785689A (en) 1996-07-18 1998-07-28 Act Medical, Inc. Endoscopic catheter sheath position control
US5655548A (en) 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US5957941A (en) 1996-09-27 1999-09-28 Boston Scientific Corporation Catheter system and drive assembly thereof
US5827313A (en) 1996-09-27 1998-10-27 Boston Scientific Corporation Device for controlled longitudinal movement of an operative element within a catheter sheath and method
US5722403A (en) 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5980887A (en) 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
EP0842640A1 (en) 1996-11-13 1998-05-20 Sulzer Osypka GmbH Heart catheter with electrode positioned on a distensible element
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US6120520A (en) 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
US5730732A (en) 1996-12-04 1998-03-24 Ethicon, Inc. Non-magnetic stainless steel surgical needle
US5935160A (en) 1997-01-24 1999-08-10 Cardiac Pacemakers, Inc. Left ventricular access lead for heart failure pacing
JP3134287B2 (en) 1997-01-30 2001-02-13 株式会社ニッショー Catheter assembly for endocardial suture surgery
US5980551A (en) 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5968064A (en) 1997-02-28 1999-10-19 Lumend, Inc. Catheter system for treating a vascular occlusion
US6045565A (en) 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6093177A (en) 1997-03-07 2000-07-25 Cardiogenesis Corporation Catheter with flexible intermediate section
US6443949B2 (en) 1997-03-13 2002-09-03 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
US6416510B1 (en) 1997-03-13 2002-07-09 Biocardia, Inc. Drug delivery catheters that attach to tissue and methods for their use
US6086582A (en) 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
DE19882286T1 (en) 1997-04-03 2000-04-27 Point Biomedical Corp Intravesical drug delivery systems
US5984908A (en) 1997-04-10 1999-11-16 Chase Medical Inc Venous return catheter having integral support member
US6099832A (en) 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
DE19734220C2 (en) 1997-08-07 2000-01-13 Pulsion Verwaltungs Gmbh & Co Catheter system with an insertion wire
AU8913998A (en) 1997-08-28 1999-03-22 Boston Scientific Corporation System for implanting a cross-linked polysaccharide fiber and methods of formingand inserting the fiber
AU9127098A (en) 1997-09-04 1999-03-22 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
US6050949A (en) 1997-09-22 2000-04-18 Scimed Life Systems, Inc. Catheher system having connectable distal and proximal portions
US6179809B1 (en) 1997-09-24 2001-01-30 Eclipse Surgical Technologies, Inc. Drug delivery catheter with tip alignment
US6183444B1 (en) 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US6371935B1 (en) 1999-01-22 2002-04-16 Cardeon Corporation Aortic catheter with flow divider and methods for preventing cerebral embolization
JP2003506310A (en) 1997-10-07 2003-02-18 リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア Treatment of occlusive peripheral vascular disease and coronary artery disease with a combination of heparin and an adenosine A2 agonist or with adenosine
IL122153A (en) 1997-11-10 2005-03-20 Alomone Labs Ltd Biocompatible polymeric coating material
US6391311B1 (en) 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
US6146373A (en) 1997-10-17 2000-11-14 Micro Therapeutics, Inc. Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6458095B1 (en) 1997-10-22 2002-10-01 3M Innovative Properties Company Dispenser for an adhesive tissue sealant having a housing with multiple cavities
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6151525A (en) 1997-11-07 2000-11-21 Medtronic, Inc. Method and system for myocardial identifier repair
US6183432B1 (en) 1997-11-13 2001-02-06 Lumend, Inc. Guidewire and catheter with rotating and reciprocating symmetrical or asymmetrical distal tip
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6217527B1 (en) 1998-09-30 2001-04-17 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US6371992B1 (en) 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
US6231546B1 (en) 1998-01-13 2001-05-15 Lumend, Inc. Methods and apparatus for crossing total occlusions in blood vessels
AU2484399A (en) 1998-01-30 1999-08-16 Scios Inc. Controlled release delivery of peptide or protein
US6221425B1 (en) 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
DE69838526T2 (en) 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Device for releasing a drug in the heart
EP0938871A3 (en) 1998-02-27 2001-03-07 ECLIPSE SURGICAL TECHNOLOGIES, Inc. Surgical apparatus
US6201608B1 (en) 1998-03-13 2001-03-13 Optical Biopsy Technologies, Inc. Method and apparatus for measuring optical reflectivity and imaging through a scattering medium
US6175669B1 (en) 1998-03-30 2001-01-16 The Regents Of The Universtiy Of California Optical coherence domain reflectometry guidewire
ATE392858T1 (en) 1998-03-31 2008-05-15 Medtronic Vascular Inc CATHETER AND SYSTEMS FOR A PERCUTANE INSITU ARTERIO-VENOUS BYPASS
US5979449A (en) 1998-04-09 1999-11-09 Steer; Eugene Lyle Oral appliance device and method for use thereof for appetite suppression
US6206914B1 (en) 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
JP4583597B2 (en) 1998-05-05 2010-11-17 ボストン サイエンティフィック リミテッド Smooth end stent
US6447504B1 (en) 1998-07-02 2002-09-10 Biosense, Inc. System for treatment of heart tissue using viability map
US6613070B2 (en) 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
US6102887A (en) 1998-08-11 2000-08-15 Biocardia, Inc. Catheter drug delivery system and method for use
AU755943B2 (en) 1998-08-13 2003-01-02 University Of Southern California Methods to increase blood flow to ischemic tissue
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6191144B1 (en) 1998-08-17 2001-02-20 Warner-Lambert Company Method of using angiotensin converting enzyme inhibitor to stimulate angiogenesis
KR20010072816A (en) 1998-08-20 2001-07-31 쿡 인코포레이티드 Coated implantable medical device
JP2002524425A (en) 1998-09-04 2002-08-06 サイオス インコーポレイテッド Hydrogel compositions for sustained release administration of growth factors
US6044298A (en) 1998-10-13 2000-03-28 Cardiac Pacemakers, Inc. Optimization of pacing parameters based on measurement of integrated acoustic noise
US6162202A (en) 1998-10-26 2000-12-19 Sicurelli; Robert Flexible syringe needle
US6635267B1 (en) 1998-11-10 2003-10-21 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for the preparation thereof and medical materials containing the same
US6761887B1 (en) 1998-11-16 2004-07-13 Osiris Therapeutics, Inc. Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
DE19855890A1 (en) 1998-12-03 2000-06-08 Nerlich Michael Porous composite matrix, its production and use
WO2000033909A1 (en) 1998-12-09 2000-06-15 Cook Incorporated Hollow, curved, superelastic medical needle
US6193763B1 (en) 1998-12-17 2001-02-27 Robert A. Mackin Apparatus and method for contemporaneous treatment and fluoroscopic mapping of body tissue
US6328229B1 (en) 1998-12-18 2001-12-11 Cohesion Technologies, Inc. Low volume mixing spray head for mixing and dispensing of two reactive fluid components
US6338717B1 (en) 1998-12-22 2002-01-15 Asahi Kogaku Kogyo Kabushiki Kaisha Tip of ultrasonic endoscope
US6210392B1 (en) 1999-01-15 2001-04-03 Interventional Technologies, Inc. Method for treating a wall of a blood vessel
US6333194B1 (en) 1999-01-19 2001-12-25 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
US6217554B1 (en) 1999-02-12 2001-04-17 Pharmaspec Corporation Methods and apparatus for delivering substances into extravascular tissue
US7615373B2 (en) 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US20020081732A1 (en) 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US20020090725A1 (en) 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US6296602B1 (en) 1999-03-17 2001-10-02 Transfusion Technologies Corporation Method for collecting platelets and other blood components from whole blood
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
JP3678602B2 (en) 1999-03-17 2005-08-03 住友ベークライト株式会社 Syringe fixed injection device
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
US6192271B1 (en) 1999-04-20 2001-02-20 Michael Hayman Radiotherapy stent
US6858229B1 (en) 1999-04-26 2005-02-22 California Institute Of Technology In situ forming hydrogels
US6159443A (en) 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US6283947B1 (en) 1999-07-13 2001-09-04 Advanced Cardiovascular Systems, Inc. Local drug delivery injection catheter
US6494862B1 (en) 1999-07-13 2002-12-17 Advanced Cardiovascular Systems, Inc. Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
US7815590B2 (en) 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US6358258B1 (en) 1999-09-14 2002-03-19 Abbott Laboratories Device and method for performing end-to-side anastomosis
US6385476B1 (en) 1999-09-21 2002-05-07 Biosense, Inc. Method and apparatus for intracardially surveying a condition of a chamber of a heart
MXPA02003009A (en) 1999-09-21 2005-02-17 Inst Cardiologie Montreal Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury.
US6368285B1 (en) 1999-09-21 2002-04-09 Biosense, Inc. Method and apparatus for mapping a chamber of a heart
US20040229856A1 (en) 1999-09-21 2004-11-18 Baskaran Chandrasekar Local delivery of 17-beta estradiol for preventing vascular intimal hyperplasia and for improving vascular endothelium function after vascular injury
US6748258B1 (en) 1999-11-05 2004-06-08 Scimed Life Systems, Inc. Method and devices for heart treatment
US6916488B1 (en) 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US6360129B1 (en) 1999-12-13 2002-03-19 Cardiac Pacemakers, Inc. Mannitol/hydrogel cap for tissue-insertable connections
US6241710B1 (en) 1999-12-20 2001-06-05 Tricardia Llc Hypodermic needle with weeping tip and method of use
US6706034B1 (en) 1999-12-30 2004-03-16 Advanced Cardiovascular Systems, Inc. Process for agent retention in biological tissues
US6547806B1 (en) 2000-02-04 2003-04-15 Ni Ding Vascular sealing device and method of use
US6346098B1 (en) 2000-03-07 2002-02-12 The Board Of Trustees Of The Leland Stanford Junior University Methods and kits for locally administering an active agent to an interstitial space of a host
AUPQ618400A0 (en) 2000-03-13 2000-04-06 Baramy Engineering Pty Ltd A gross pollutant trap
US6458098B1 (en) 2000-03-17 2002-10-01 Nozomu Kanesaka Vascular therapy device
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
US6589549B2 (en) 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
AU2001273034A1 (en) 2000-06-26 2002-01-08 Rxkinetix, Inc. Composition for delivery of hematopoietic growth factor
DE60133744T2 (en) 2000-07-28 2009-05-14 Anika Therapeutics, Inc., Woburn BIOABSORBABLE COMPOSITE MATERIALS FROM DERIVATED HYALURONIC ACID
US6478775B1 (en) 2000-10-02 2002-11-12 Genyx Medical Inc. Device for delivering non-biodegradable bulking composition to a urological site
US6554801B1 (en) 2000-10-26 2003-04-29 Advanced Cardiovascular Systems, Inc. Directional needle injection drug delivery device and method of use
US20020072706A1 (en) 2000-12-11 2002-06-13 Thomas Hiblar Transluminal drug delivery catheter
US6846319B2 (en) 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
US6692466B1 (en) 2000-12-21 2004-02-17 Advanced Cardiovascular Systems, Inc. Drug delivery catheter with retractable needle
US6599267B1 (en) 2000-12-22 2003-07-29 Advanced Cardiovascular Systems, Inc. Transluminal injection device for intravascular drug delivery
MXPA03006315A (en) 2001-01-16 2004-12-03 Vascular Therapies Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
US6602241B2 (en) 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US6565530B2 (en) 2001-02-28 2003-05-20 Scimed Life Systems, Inc. Immobilizing objects in the body
DE60208780T2 (en) 2001-02-28 2006-08-10 Rex Medical, L.P. DEVICE FOR APPLYING ABLATION FLUID FOR THE TREATMENT OF LESIONS
US20020124855A1 (en) 2001-03-12 2002-09-12 Chachques Juan C. Method of providing a dynamic cellular cardiac support
US7029838B2 (en) 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
US7396582B2 (en) 2001-04-06 2008-07-08 Advanced Cardiovascular Systems, Inc. Medical device chemically modified by plasma polymerization
US6628988B2 (en) 2001-04-27 2003-09-30 Cardiac Pacemakers, Inc. Apparatus and method for reversal of myocardial remodeling with electrical stimulation
US7311731B2 (en) 2001-04-27 2007-12-25 Richard C. Satterfield Prevention of myocardial infarction induced ventricular expansion and remodeling
US20020188170A1 (en) 2001-04-27 2002-12-12 Santamore William P. Prevention of myocardial infarction induced ventricular expansion and remodeling
US6660034B1 (en) 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US6723067B2 (en) 2001-07-26 2004-04-20 David H. Nielson Apparatus for delivering aerosolized fibrin endoscopically to a wound
EP1423175B1 (en) 2001-08-08 2013-10-02 Brown University Research Foundation Methods for micronization of hydrophobic drugs
US6663596B2 (en) 2001-08-13 2003-12-16 Scimed Life Systems, Inc. Delivering material to a patient
JP2003062089A (en) 2001-08-24 2003-03-04 Sumitomo Bakelite Co Ltd Connector for medical application
US7037289B2 (en) 2001-09-12 2006-05-02 3M Innovative Properties Company Apparatus and methods for dispensing an adhesive tissue sealant
US6790455B2 (en) 2001-09-14 2004-09-14 The Research Foundation At State University Of New York Cell delivery system comprising a fibrous matrix and cells
US7112587B2 (en) 2001-09-21 2006-09-26 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
US6893431B2 (en) 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
CN1328319C (en) 2001-11-07 2007-07-25 苏黎世大学 Synthetic matrix for controlled cell ingrowth and tissue regeneration
US7035092B2 (en) 2001-11-08 2006-04-25 Apple Computer, Inc. Computer controlled display device
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US6973349B2 (en) 2001-12-05 2005-12-06 Cardiac Pacemakers, Inc. Method and apparatus for minimizing post-infarct ventricular remodeling
US7169127B2 (en) 2002-02-21 2007-01-30 Boston Scientific Scimed, Inc. Pressure apron direct injection catheter
JP4229621B2 (en) 2002-03-05 2009-02-25 修 加藤 Chemical injection catheter
US20030175410A1 (en) 2002-03-18 2003-09-18 Campbell Phil G. Method and apparatus for preparing biomimetic scaffold
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US7008411B1 (en) 2002-09-30 2006-03-07 Advanced Cardiovascular Systems, Inc. Method and apparatus for treating vulnerable plaque
US7438692B2 (en) 2002-10-18 2008-10-21 Mark Tsonton Localization mechanism for an MRI compatible biopsy device
JP2006516548A (en) * 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト Drug delivery from rapidly gelled polymer compositions
US7393339B2 (en) 2003-02-21 2008-07-01 C. R. Bard, Inc. Multi-lumen catheter with separate distal tips
US7250041B2 (en) 2003-03-12 2007-07-31 Abbott Cardiovascular Systems Inc. Retrograde pressure regulated infusion
US20050015048A1 (en) 2003-03-12 2005-01-20 Chiu Jessica G. Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
ES2440654T3 (en) 2003-05-05 2014-01-29 Ben-Gurion University Of The Negev Research And Development Authority Injectable crosslinked polymeric preparations and uses thereof
EP1649008A2 (en) 2003-07-16 2006-04-26 Boston Scientific Limited Aligned scaffolds for improved myocardial regeneration
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7169404B2 (en) * 2003-07-30 2007-01-30 Advanced Cardiovasular Systems, Inc. Biologically absorbable coatings for implantable devices and methods for fabricating the same
WO2005018697A2 (en) 2003-08-13 2005-03-03 Medtronic, Inc. Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods
US7998112B2 (en) 2003-09-30 2011-08-16 Abbott Cardiovascular Systems Inc. Deflectable catheter assembly and method of making same
AU2004305574B2 (en) 2003-12-10 2010-08-26 Cellular Bioengineering, Inc. Methods and composition for soft tissue feature reconstruction
US7273469B1 (en) 2003-12-31 2007-09-25 Advanced Cardiovascular Systems, Inc. Modified needle catheter for directional orientation delivery
US20050186240A1 (en) * 2004-02-23 2005-08-25 Ringeisen Timothy A. Gel suitable for implantation and delivery system
WO2006083260A2 (en) 2004-04-28 2006-08-10 Angiotech Biomaterials Corporation Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
GB0419653D0 (en) 2004-09-04 2004-10-06 Psimedica Ltd Needle assembly
TW200633733A (en) 2004-12-07 2006-10-01 Gelwell Biotech Corp Biomaterials for guided tissue regeneration and drug delivery
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
JP4762785B2 (en) * 2005-06-02 2011-08-31 西川ゴム工業株式会社 Gelatin sponge
EP2623116A1 (en) 2005-07-27 2013-08-07 Eli Lilly and Company A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
US7732190B2 (en) 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
US8221744B2 (en) 2007-09-19 2012-07-17 Abbott Cardiovascular Systems Inc. Cytocompatible alginate gels

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818291A (en) * 1986-12-10 1989-04-04 Ajinomoto Co., Inc. Silk-fibroin and human-fibrinogen adhesive composition
WO2003022909A1 (en) * 2001-09-11 2003-03-20 Consorzio Per Gli Studi Universitari Method for the preparation of silk fibroin hydrogels
WO2004000915A2 (en) * 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HANAWA T ET AL: "NEW ORAL DOSAGE FORM FOR ELDERLY PATIENTS: PREPARATION AND CHARACTERIZATION OF SILK FIBROIN GEL", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, vol. 43, no. 2, 1 January 1995 (1995-01-01), pages 284 - 288, XP001120505, ISSN: 0009-2363 *
KIM UNG-JIN ET AL: "Structure and properties of silk hydrogels.", BIOMACROMOLECULES 2004 MAY-JUN, vol. 5, no. 3, May 2004 (2004-05-01), pages 786 - 792, XP002488460, ISSN: 1525-7797 *
KWEON H Y ET AL: "Preparation of semi-interpenetrating polymer networks composed of silk fibroin and poly(ethylene glycol) macromer", JOURNAL OF APPLIED POLYMER SCIENCE, JOHN WILEY AND SONS INC. NEW YORK, US, vol. 80, 1 January 2001 (2001-01-01), pages 1848 - 1853, XP002973765, ISSN: 0021-8995 *

Also Published As

Publication number Publication date
JP2014121652A (en) 2014-07-03
EP2099509B1 (en) 2016-09-21
US20080131509A1 (en) 2008-06-05
US8465773B2 (en) 2013-06-18
US8192760B2 (en) 2012-06-05
US8465772B2 (en) 2013-06-18
JP2010511426A (en) 2010-04-15
JP5823094B2 (en) 2015-11-25
US20130251764A1 (en) 2013-09-26
EP2099509A2 (en) 2009-09-16
US20120225040A1 (en) 2012-09-06
US8828436B2 (en) 2014-09-09
US20120225041A1 (en) 2012-09-06
WO2008069919A2 (en) 2008-06-12
JP5853045B2 (en) 2016-02-09

Similar Documents

Publication Publication Date Title
WO2008069919A3 (en) Methods & compositions for treating tissue using silk proteins
WO2004009774A3 (en) Protein conjugates with a water-soluble biocompatible, biogradable polymer
WO2004011611A3 (en) Taci antibodies and uses thereof
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
DE602005007293D1 (en) Hyperbranched polymer, composition containing the same and cosmetic method
ATE494010T1 (en) THERAPEUTIC DELIVERY COMPOSITIONS AND OTHER MATERIALS AND METHODS FOR THE PRODUCTION AND USE THEREOF
WO2005001077A3 (en) Repair and regeneration of ocular tissue using postpartum-derived cells
WO2005028631A3 (en) A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same
DE60205624D1 (en) METHODS OF MAKING ESPECIALLY MONODISPERSE POLYMER MIXTURES WITH POLYETHYLENE GLYCLE UNITS
WO2005103076A3 (en) Erythropoietin protein variants
SG102636A1 (en) Polar group-containing olefin copolymer, process for preparing the same, thermoplatic resin composition containing the copolymer, and uses thereof
CY1112330T1 (en) CONNECTION PROTEINS GAG
WO2009153750A3 (en) Improved cross-linked compositions
HK1080497A1 (en) Carbohydrate-modified polymers, compositions and uses related thereto
AU2003281621A8 (en) Modified calcium carbonate, polymer composition containing the same and process for producing them
DE60314865D1 (en) METHOD FOR THE PRODUCTION OF MODIFIED POLYMER, THEREFORE MODIFIED POLYMER AND RUBBER COMPOSITION
WO2007136504A3 (en) Medical devices having bioactive surfaces
ATE494012T1 (en) STABILIZED POLYMER THIOL REAGENTS
EP2289944A3 (en) Bispecific antibody substituting for functional proteins
DE602006020056D1 (en) DIMERCAPTANTERMINIERTE POLYTHIOETHERPOLYMERE AND METHOD FOR THE PRODUCTION AND THEIR USE
WO2009080668A3 (en) Composition comprising an alkanolamine, an amino acid and a cationic polymer
WO2007075438A3 (en) Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
WO2007081419A3 (en) Compositions and methods related to anti-fgf agents
WO2009151520A3 (en) Biocompatible and biodegradable elastomeric polymers
EP1967590A3 (en) Lentiviral packaging constructs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870900

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2007870900

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007870900

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2009539265

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE